-
-
-
-
-
-
-
Aptar Digital Health partners with Enable Injections for enFuse companion app
-
-
-
-
-
-
-
Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
-
-
-
-
-
-
-
AptarGroup (ATR) Tops Q2 EPS by 7c; offers guidance
-
-
-
-
-
-
-
Raymond James Starts AptarGroup (ATR) at Outperform
-
-
-
-
-
-
-
AptarGroup (ATR) PT Raised to $174 at BofA Securities
-
-
-
434,564 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

